Invitrogen shareholders to decide merger with Applied Biosystems on Oct. 16

By Lisa Kerner

Charlotte, N.C., Aug. 25 - Invitrogen Corp. shareholders will vote on the company's proposed acquisition of Applied Biosystems Inc. (formerly Applera Corp.) at a special meeting on Oct. 16 at noon ET in Carlsbad, Calif.

Record date for the meeting is Sept. 5, according to a company news release.

In June, Invitrogen agreed to acquire Applied Biosystems for $38 per share in a cash and stock transaction valued at $6.7 billion.

The transaction is subject to approval by both companies' shareholders and the European Commission in addition to other customary closing conditions, Invitrogen noted.

It was recently announced that the acquisition may close in late October or early November.

Invitrogen is a Carlsbad, Calif.-based provider of life science technologies for disease research, drug discovery and commercial bioproduction.

Applied Biosystems is a developer and marketer of instrument-based systems, consumables, software and services. The company is located in Norwalk, Conn.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.